Donald Zakrowski - Eli Lilly Chief Fin

LLY Stock   764.20  33.50  4.58%   

Insider

Donald Zakrowski is Chief Fin of Eli Lilly and
Phone317 276 2000
Webhttps://www.lilly.com

Donald Zakrowski Latest Insider Activity

Tracking and analyzing the buying and selling activities of Donald Zakrowski against Eli Lilly stock is an integral part of due diligence when investing in Eli Lilly. Donald Zakrowski insider activity provides valuable insight into whether Eli Lilly is net buyers or sellers over its current business cycle. Note, Eli Lilly insiders must abide by specific rules, including filing SEC forms every time they buy or sell Eli Lilly'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Eli Lilly Management Efficiency

The company has return on total asset (ROA) of 0.11 % which means that it generated a profit of $0.11 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6267 %, meaning that it generated $0.6267 on every $100 dollars invested by stockholders. Eli Lilly's management efficiency ratios could be used to measure how well Eli Lilly manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Katie HodgsonTreasury Wine Estates
N/A
Tom KingTreasury Wine Estates
N/A
Meiko KogaSekisui Chemical Co
N/A
Michelle BramptonTreasury Wine Estates
N/A
Karl McDonnellStrategic Education
57
Ikusuke ShimizuSekisui Chemical Co
59
Masaki MiyajimaShin Etsu Chemical Co
N/A
Kristy KeyteTreasury Wine Estates
N/A
Katsunori MukaiSekisui Chemical Co
N/A
Tatsuya NishidaSekisui Chemical Co
N/A
Susumu UenoShin Etsu Chemical Co
80
Futoshi KamiwakiSekisui Chemical Co
63
Fumio AraiShin Etsu Chemical Co
N/A
BALLB BATreasury Wine Estates
N/A
Yukihito AdachiShin Etsu Chemical Co
N/A
Yoshiyuki HiraiSekisui Chemical Co
60
BEng BETreasury Wine Estates
N/A
Toshiyuki KamiyoshiSekisui Chemical Co
62
Tal DarmonStrategic Education
48
Yukihiro MatsuiShin Etsu Chemical Co
N/A
Ben DollardTreasury Wine Estates
N/A
Eli Lilly and (LLY) is traded on XETRA Stock Exchange in Germany and employs 39,000 people.

Management Performance

Eli Lilly Leadership Team

Elected by the shareholders, the Eli Lilly's board of directors comprises two types of representatives: Eli Lilly inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eli. The board's role is to monitor Eli Lilly's management team and ensure that shareholders' interests are well served. Eli Lilly's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eli Lilly's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Ricks, CEO Chairman
Jacob Naarden, CEO VP
Alonzo Weems, VP Officer
Diogo Rau, VP Officer
Donald Zakrowski, Chief Fin
Anat Ashkenazi, VP CFO
Leigh Pusey, Sr Communications
Martin MIBS, VP Projects
Anat JD, Gen VP

Eli Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Eli Lilly a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.